Hospital Discharges for Prescription Opioids Have Fallen

This article originally appeared here.
Share this content:
Hospital Discharges for Prescription Opioids Have Fallen
Hospital Discharges for Prescription Opioids Have Fallen

TUESDAY, Oct. 3, 2017 (HealthDay News) -- Prescription opioid-related inpatient and emergency department (ED) discharges have decreased since 2010, while heroin-related discharges have increased sharply since 2008, according to a study published online Oct. 2 in Health Affairs.

Dario Tesdesco, Ph.D., from Stanford University in California, and colleagues examined national trends in inpatient and emergency department discharges for opioid abuse, dependence, and poisoning using data from the Healthcare Cost and Utilization Project for 1997 to 2014 (inpatient discharges) and for 2006 to 2014 (ED discharges).

The researchers found that there was an increase in overall opioid-related inpatient and ED discharge rates in the U.S. population. Starting in 2010, prescription opioid-related discharges decreased, coinciding with national, state, and local initiatives. There was a sharp increase in heroin-related discharges starting in 2008.

"The decrease in prescription opioid-related discharges gives hope that health care providers, nonmedical first responders, and families are appropriately responding to safety initiatives," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Doctors Urged to Speak With Patients About Firearms

Doctors Urged to Speak With Patients About Firearms

Making a public commitment is encouraged as a positive action that physicians can take

Machine Learning Model Predicts Risk of Upgrade to Breast CA

Machine Learning Model Predicts Risk of Upgrade to ...

Model can predict risk of upgrade of high-risk breast lesions to cancer using traditional, text features

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

Glycemic Control Up With Oral Semaglutide in Type ...

Phase 3 studies next to assess longer-term/clinical outcomes, safety

is free, fast, and customized just for you!

Already a member?

Sign In Now »